Trial · NCT01628848
Results by group32
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 32
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Unified Parkinson's Disease Rating Scale (UPDRS) Part 3 Sum Score | SPM 962 | -10.1 | Standard Deviation 9.0 | Scores on a scale | |
| Unified Parkinson's Disease Rating Scale (UPDRS) Part 3 Sum Score | Placebo | -4.4 | Standard Deviation 7.4 | Scores on a scale | |
| UPDRS Part 2 Sum Score (Average Score of on State and Off State) | SPM 962 | -3.8 | Standard Deviation 3.6 | Scores on a scale | |
| UPDRS Part 2 Sum Score (Average Score of on State and Off State) | Placebo | -1.6 | Standard Deviation 2.6 | Scores on a scale | |
| Off Time | SPM 962 | -2.1 | Standard Deviation 3.1 | Hours | |
| Off Time | Placebo | -0.7 | Standard Deviation 2.8 | Hours | |
| Effective Rate in UPDRS Part 3 Sum Score | SPM 962 | Subjects with ≥20% decrease | 73.3 | 95% Confidence Interval 63.9 to 82.6 | Percentage of participants |
| Effective Rate in UPDRS Part 3 Sum Score | Placebo | Subjects with ≥20% decrease | 43.0 | 95% Confidence Interval 32.6 to 53.5 | Percentage of participants |
| Effective Rate in UPDRS Part 3 Sum Score | SPM 962 | Subjects with ≥30% decrease | 64.0 | 95% Confidence Interval 53.8 to 74.1 | Percentage of participants |
| Effective Rate in UPDRS Part 3 Sum Score | Placebo | Subjects with ≥30% decrease | 29.1 | 95% Confidence Interval 19.5 to 38.7 | Percentage of participants |
| UPDRS Part 1 Sum Score | SPM 962 | -0.15 | Standard Deviation 1.34 | Scores on a scale | |
| UPDRS Part 1 Sum Score | Placebo | -0.12 | Standard Deviation 0.79 | Scores on a scale | |
| Effective Rate in Off Time | SPM 962 | Subjects with ≥20% decrease | 63.0 | 95% Confidence Interval 50.1 to 75.8 | Percentage of participants |
| Effective Rate in Off Time | Placebo | Subjects with ≥20% decrease | 46.4 | 95% Confidence Interval 33.4 to 59.5 | Percentage of participants |
| Effective Rate in Off Time | SPM 962 | Subjects with ≥30% decrease | 51.9 | 95% Confidence Interval 38.5 to 65.2 | Percentage of participants |
| Effective Rate in Off Time | Placebo | Subjects with ≥30% decrease | 37.5 | 95% Confidence Interval 24.8 to 50.2 | Percentage of participants |
| UPDRS Part 2 Sum Score (on State) | SPM 962 | -3.0 | Standard Deviation 3.7 | Scores on a scale | |
| UPDRS Part 2 Sum Score (on State) | Placebo | -1.2 | Standard Deviation 2.6 | Scores on a scale | |
| UPDRS Part 2 Sum Score (Off State) | SPM 962 | -4.6 | Standard Deviation 4.5 | Scores on a scale | |
| UPDRS Part 2 Sum Score (Off State) | Placebo | -1.9 | Standard Deviation 3.6 | Scores on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01628848/results